HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

MDX-1342 antibody

a nonfucosylated anti-CD19 antibody

Also Known As:

MDX 1342; MDX-1342; MDX1342 antibody

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Blood Proteins: 12459
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        MDX-1342 antibody: 1
    - Immunoproteins: 43
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        MDX-1342 antibody: 1
  - Globulins: 3062
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        MDX-1342 antibody: 1

Experts

1.	Blanset, Diann: 1 article (02/2010)
2.	Cardarelli, Pina M: 1 article (02/2010)
3.	Chen, Sharline: 1 article (02/2010)
4.	Huang, Haichun: 1 article (02/2010)
5.	King, David J: 1 article (02/2010)
6.	Kuhne, Michelle R: 1 article (02/2010)
7.	Liu, Jie: 1 article (02/2010)
8.	Moldovan-Loomis, Maria-Cristina: 1 article (02/2010)
9.	Pan, Chin: 1 article (02/2010)
10.	Passmore, David: 1 article (02/2010)

Related Diseases

1.	B-Cell Lymphoma (Lymphoma, B Cell) 02/01/2010 - "MDX-1342 showed dose-dependent improvement in survival using a murine B-cell lymphoma model in which Ramos cells were administered systemically. "
2.	Neoplasms (Cancer) 02/01/2010 - "In vivo administration of MDX-1342 in cynomolgus monkeys revealed potent B-cell depletion, suggesting its potential utility as a B-lymphocyte depletive therapy for malignancies and autoimmune indications."

Related Therapies and Procedures

1.	Therapeutics